Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Business School in top ranks of survey
2012-02-15

 
UFS Business School
Photo: Liezl Muller

The UFS Business School was ranked amongst the top business schools in South Africa in a survey by Finweek and MBAConnect.net. MBAConnect.net is the biggest social network for MBA graduates in South Africa. 

More than 10 000 MBA graduates and students were invited to take part in the survey and 1 575 of them completed it. More than half of the respondents are in senior or executive positions.
 
Prof. Helena van Zyl, the Director of the UFS Business School, says any business school has a moral obligation towards its alumni to ensure that the quality of the qualification that they obtained is maintained, that network opportunities are created for graduates, and that job opportunities are communicated, etc. Investment in and involvement with the alumni are non-negotiable as they form the backbone of a business school.
 
The UFS Business School’s results are listed below. The respondents rated the school as the school with the highest:
  • percentage of respondents saying they had definitely made the right choice in doing an MBA: second with 92% (average 86%)
  • score in leadership effectiveness: third with 8.9 (average 8.7)
  • decision-making effectiveness: shares first place with 9.4 (average 9.1)
  • credibility in business: second with 8.9 (average 8.6)
  • impact of an MBA in changing industries: third with 8.3 (average 7.9)
  • score for influence of an MBA in starting your own business: second with 8.5 (average 6.9)
  • percentage of respondents saying an MBA was definitely worth the price paid: shares first place with 80% (average 72%)
  • score for changing the outlook of students: shares first place with 9.3 (average 8.9)
  • score for improving people’s views of their own potential: shares first place with 9.5 (average 9.1)
  • score for helping people become better leaders in their personal lives: shares third place with 8.3 (average 7.8).
The UFS Business School shared first place with its alumni averaging the shortest payback period amongst those who thought the MBA was worth it. Its score was 1.1 years (average 1.8 years)
 
The report says across all schools, at least 73% of students report a negative impact on their stress levels. In the worst case, this goes up to 94%. The impact on the UFS’s students was the lowest at 18%. The average was 81%. At least a quarter of students in all schools report a negative impact on their health, and it goes up to 47% in the worst case. The UFS got 0 (nil) in the category for serious impact.
 
Alumni of the UFS Business School were very satisfied with the school. These results are as follows:
  • Helps keep business knowledge up to date: third (6.5)
  • Provides networking opportunities: first (7.3)
  • Informs about business events: second (8.9)
  • Communicates regularly: first (9.2)
  • Helps access MBA-level jobs: second (6.2)
  • Helps build personal brand: first (5.2)
  • Helps start or grow business: first (5.2)
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept